Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels

Journal of Internal Medicine
S Marcovina, C J Packard

Abstract

Apolipoproteins AI and B are structural components of lipoprotein particles, and also determinants of the metabolic fate of the encapsulated lipid, cholesterol and triglyceride. Development of accurate assays for these apolipoproteins has opened the way for their use as predictors of coronary heart disease risk. Interpretation of AI and apo B levels is best undertaken with background knowledge of the metabolic status of an individual, especially the lipolytic capacity as reflected in the triglyceride concentration. Those with raised triglyceride, in general, not only have an elevated apo B/apo AI ratio, but also apo B-containing lipoproteins with a prolonged residence time and hence ample opportunity for modification and damage. Assessment of apolipoprotein levels is an aid to risk prediction and can be useful in tailoring treatment.

References

Jul 1, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·R MalmströmM R Taskinen
Jan 23, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·C J Packard, J Shepherd
Sep 17, 1999·Atherosclerosis·K A RyeP J Barter
Dec 3, 1999·Journal of Internal Medicine·F Karpe
Nov 22, 2000·Current Opinion in Lipidology·R J Havel
Apr 13, 2001·JAMA : the Journal of the American Medical Association·S J RobinsUNKNOWN VA-HIT Study Group. Veterans Affairs High-Density Lipoprotein Intervention Trial
Sep 18, 2002·Journal of Lipid Research·Kaspar K Berneis, Ronald M Krauss
Jun 13, 2003·Atherosclerosis·Philip BarterUNKNOWN Future Forum Editorial Board
Mar 17, 2004·Current Opinion in Lipidology·Marlys L Koschinsky, Santica M Marcovina
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Nan WangAlan R Tall
Aug 3, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Dick C ChanGerald F Watts
Jun 4, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Nirupa R MatthanAlice H Lichtenstein
Jun 25, 2005·Circulation Research·Gary F Lewis, Daniel J Rader

❮ Previous
Next ❯

Citations

Aug 12, 2006·Current Atherosclerosis Reports·Natalie Khuseyinova, Wolfgang Koenig
Jan 5, 2008·Current Atherosclerosis Reports·Allan D Sniderman, Robert S Kiss
Jul 21, 2011·Current Atherosclerosis Reports·Sandeep S Mangalmurti, Michael H Davidson
Apr 5, 2012·Metabolic Syndrome and Related Disorders·Alireza EsteghamatiManouchehr Nakhjavani
Jan 4, 2013·PloS One·You-Cheol HwangSung-Woo Park
Dec 10, 2008·The American Journal of Clinical Nutrition·Kimber L Stanhope, Peter J Havel
Jul 13, 2011·Journal of Endocrinological Investigation·L Tian, M Fu
Jul 16, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Min Kyung KimKyung Rae Kim
May 8, 2008·Journal of the American College of Nutrition·Maria Luz Fernandez, Densie Webb
May 1, 2010·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Timothy P YorkJason W Flora
Jan 24, 2012·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Helen M HeneghanTakhar Kasumov
May 18, 2011·Fertility and Sterility·Chung-Yu ChangJuin-Huang Su
Dec 6, 2007·The Canadian Journal of Cardiology·Isabelle LemieuxJean-Pierre Després
Sep 15, 2009·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·T Al-SarrajM L Fernandez
Apr 17, 2009·The Journal of Nutritional Biochemistry·Gisella MutungiMaria Luz Fernandez
Dec 17, 2008·American Heart Journal·Michal BenderlyUri Goldbourt
Nov 26, 2014·Japanese Journal of Infectious Diseases·Tanida SuwalakChonlaphat Sukasem
Jul 17, 2007·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Göran Walldius, Ingmar Jungner
May 23, 2007·Journal of Cardiac Failure·Grigorios Giamouzis, Javed Butler
Sep 11, 2009·Clinical Cardiology·Michael H Davidson
Jun 17, 2008·Journal of Internal Medicine·A Romero-CorralF Lopez-Jimenez
Dec 27, 2011·Pathology·Damon A BellJohn R Burnett
Sep 30, 2010·Analytical Biochemistry·Jonas MelinChristina Jönsson
Jan 5, 2012·Scandinavian Journal of Urology and Nephrology·S LundbergS H Jacobson
Apr 9, 2015·Disease Markers·Anastasiya M KanevaJon Ø Odland

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.